---
title: Metabolic Emergencies
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Metabolic Emergencies #ğŸš§ æ–½å·¥ä¸­

### Metabolic Emergencies

Hypercalcemia of malignancy

â€¢Â Â Â Pathophysiology: Multiple possible mechanisms

-Â Â Â Tumor secretion of PTHrP (most common) â€“ often SCC of lung, breast cancer, RCC

-Â Â Â Osteolytic metastases, which cause increased bone turnover â€“ commonly MM, breast cancer

-Â Â Â Tumor production of 1,25-OH Vit D â€“ Hodgkinâ€™s and NH lymphoma

â€¢Â Â Â Symptoms: â€œStones, groans, moans, psychiatric overtonesâ€ â€“ kidney stones, nausea, vomiting, abdominal pain, bony pain, AMS

â€¢Â Â Â Diagnosis: â†‘Ca2\+ level (corrected for albumin), dehydration (â†‘Cr, â†‘Na\+)

â€¢Â Â Â Treatment:

-Â Â Â Aggressive hydration (200â€“300 mL/hr to maintain UOP of 100â€“150 ml/hr). Caution in heart failure and volume overload. Generally only use diuretics if there is concern for iatrogenic hypervolemia. Effect seen: Hours.

-Â Â Â Calcitonin 4IU/kg Q6â€“12 hrs for up to 48 hrs (patients will develop tachyphylaxis after 48 hrs of therapy). Effect seen: Hours to days.

-Â Â Â Bisphosphonate: Usually zoledronic acid. One-time dose, so full dose ok in renal dysfunction and no dental evaluation needed prior to treatment. Effect seen: 2â€“4 days.

-Â Â Â Denosumab: Monoclonal antibody to RANK-ligand â†’ blocks activation of osteoclasts, which promote bone breakdown and Ca2\+ release. Generally, bisphosphonates are preferred over denosumab for acute treatment of hypercalcemia of malignancy. Effect seen: 4â€“10 days.

##### Neutropenic fever

â€¢Â Â Â See details in the hematology section under oncologic emergencies

##### DIC and TLS

â€¢Â Â Â Less common with solid than hematologic malignancies but can occur with solid tumor malignancies

â€¢Â Â Â See details in the hematology section under oncologic emergencies

